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Abstract Intestinal microbial community structure is
driven by host genetics in addition to environmental factors
such as diet. In comparison with environmental influences,
the effect of host genetics on intestinal microbiota, and
how host-driven differences alter host metabolism is
unclear. Additionally, the interaction between host genetics
and diet, and the impact on the intestinal microbiome and
possible down-stream effect on host metabolism is not
fully understood, but represents another aspects of inter-
individual variation in disease risk. The objectives of this
study were to investigate how diet and genetic background
shape microbial communities, and how these diet- and
genetic-driven microbial differences relate to cardiometa-
bolic phenotypes. To determine these effects, we used the 8
progenitor strains of the collaborative cross/diversity out-
bred mapping panels (C57BL/6J, A/J, NOD/ShiLtJ, NZO/
HILtJ, WSB/EiJ, CAST/EiJ, PWK/PhJ, and 129S1/SvImJ).
16s rRNA profiling of enteric microbial communities in
addition to the assessment of phenotypes central to car-
diometabolic health was conducted under baseline
nutritional conditions and in response to diets varying in
atherogenic nutrient (fat, cholesterol, cholic acid) compo-
sition. These studies revealed strain-driven differences in
enteric microbial communities which were retained with
dietary intervention. Diet–strain interactions were seen for
a core group of cardiometabolic-related microbial taxa. In
conclusion, these studies highlight diet and genetically
regulated cardiometabolic-related microbial taxa. Further-
more, we demonstrate the progenitor model is useful for
nutrigenomic-based studies and screens seeking to inves-
tigate the interaction between genetic background and the
phenotypic and microbial response to diet.
Introduction
The intestinal microbiome is associated with susceptibility
to and development of several chronic metabolic diseases
including diabetes (Larsen et al. 2010), obesity (Turnbaugh
et al. 2008), and cardiovascular disease (Karlsson et al.
2012). Negative changes in host adiposity, metabolic syn-
drome status, and insulin sensitivity can be directly induced
by microbial dysbiosis (Ridaura et al. 2013; Vijay-Kumar
et al. 2010; Vrieze et al. 2012). Considering the inter-
individual variability at the level of the microbiome
(Eckburg et al. 2005; Qin et al. 2010), detailed studies
integrating the intestinal microbiome with disease risk
complements current genome wide association studies and
other efforts seeking to understand heterogeneity in health
and disease status. We, among others (Kaput 2008; Perez-
Martinez et al. 2013) recognize that a ‘one size fits all’
approach to optimal nutritional and health status is not
addressing the current epidemics of obesity, cardiovascular
disease, and diabetes. In particular, understanding how
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microbial diversity and specific microbial species affect
clinical phenotypes and risk of disease is necessary.
Research models which simultaneously permit both die-
tary- and genetic-driven perturbations are an essential step
in developing personalized approaches to nutrition and
medicine.
As the role of genetics in driving disease-susceptibility
is being more fully elucidated, the influence of genetic
background on the regulation of microbial diversity is also
becoming established. Several groups have reported that
enteric microbial composition is a heritable trait (Tims
et al. 2013; Turnbaugh et al. 2010), although results from
twin studies have been discordant (Turnbaugh et al. 2009).
However, studies using mouse genetic panels, as well as
those exploiting single-gene mutations, have consistently
shown an effect of host genetics on intestinal microbial
community structure (Benson et al. 2010; Kovacs et al.
2011; McKnite et al. 2012; Parks et al. 2013a; Spor et al.
2011; Toivanen et al. 2001), and may have increased power
to detect genotype-driven microbial differences, as murine
studies allow for tight control over environmental factors
(Benson et al. 2010).
In addition to the influence of genetic background, sig-
nificant advances have been made in understanding envi-
ronmental determinants of microbial structure including
maternal effects, cage mates, gender, and diet (Spor et al.
2011). As a source of essential nutrients for the intestinal
microbiota, host-consumed diet is an important determi-
nant of microbial community structure in the intestine, and
dynamic changes in both mouse and human microbial
populations occur in response to dietary intervention (Spor
et al. 2011). Although environmental influences have a
strong effect, and can be dominant in certain cases, geno-
type–environmental interactions have been shown to con-
tribute to microbial diversity (Parks et al. 2013a), as well as
risk of disease (Parks et al. 2013a; Srinivas et al. 2013).
It is not known how host genotype-driven differences in
the intestinal microbiome are related to host cardiometa-
bolic phenotype. Using a segregating panel of mice phe-
notyped for clinically relevant metabolic and atherogenic
makers, the objectives of this study were to identify host-
genetic-derived differences in the intestinal microbiome
and determine how these differences are related to host
phenotype under baseline nutritional intake, and following
consumption of an atherogenic diet. Recently, a ‘‘multi-
parent advanced generation inter-cross’’ (MAGIC) popu-
lation was developed from 8 inbred mouse strains, and is
referred to as the diversity outbred (DO) mouse population
(Churchill et al. 2012). The DO mice are mosaics of
C57BL/6J, A/J, NOD/ShiLtJ, NZO/HILtJ, WSB/EiJ,
CAST/EiJ, PWK/PhJ, and 129S1/SvImJ, and these mice
complement another large endeavor called the collabora-
tive cross (CC)(Aylor et al. 2011). These eight founder
strains of the CC/DO are genetically diverse and capture
*90 % of the known genetic variation in the mouse
(Roberts et al. 2007). Here we present data investigating
the microbial community diversity in the CC/DO founder
stains. Discriminatory microbiota are related to cardio-
metabolic phenotypes, and the microbial and phenotypic
response to dietary factors is investigated and discussed.
We demonstrate that this model is useful for nutrigenomic-
based studies seeking to investigate the interaction between




All experiments were approved by the Institutional Animal
Care and Use Committee (IACUC) at the North Carolina
Research Campus (NCRC). All mice used in these studies
were female. Mice were purchased from Jackson Labora-
tories (Bar Harbor, ME, USA) at 4 weeks of age. Mice
were group housed by strain (2 cages/strain, 4 animals/
cage) under standard conditions (12 h light:dark, temper-
ature- and humidity-controlled conditions), and received ad
lib access to water and a nutritionally complete purified
synthetic diet containing 9.4 % kcal from fat, 75.9 % kcal
from carbohydrate and 14.7 % kcal from protein (AIN-
93M; (#D10012M); Research Diets Inc, New Brunswick,
NJ, USA). After 4 weeks on AIN-93 M, mice were ran-
domized to diet (n = 4/diet group) for a further 16 weeks
as follows: (1) a defined atherogenic diet, containing 20 %
kcal as fat, 20 % kcal as protein, 40 % kcal from carbo-
hydrate, 1.25 % cholesterol, and 0.5 % cholic acid,
(#D12109C, Research Diets Inc, New Brunswick, NJ,
USA), abbreviated to high fat cholic acid (HFCA) diet; or,
(2) a low-fat cholesterol-containing diet without cholic acid
(10 % kcal as fat, 20 % kcal as protein, 70 % kcal as
carbohydrate, 1.25 % cholesterol) (#D12104C, Research
Diets Inc, New Brunswick, NJ, USA), abbreviated to low-
fat (LF) diet. The protein sources (casein and L-cystine)
were consistent across diets, as were sources of carbohy-
drate (cornstarch, maltodextrin, sucrose). Additionally, the
type and amount of polysaccharide (cellulose) were com-
parable between diets. The source of fat (soybean oil for
AIN-93M versus soybean oil plus cocoa butter for HFCA
and LF) varied between the diets. The increased levels of
cholic acid, cholesterol, and dietary fat were selected to
induce hyperlipidemia and atherosclerosis (Getz and
Reardon 2006). A 16 weeks dietary intervention is suffi-
cient to observe aortic lesion formation (Hyman et al.
1994).
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Body composition
Body composition (proportion of fat mass) was assessed
using EchoMRITM-100H (Echo MRI LLC, Houston, TX,
USA).
Plasma metabolic markers
Mice were fasted for 4 h before blood draw via retro-orbital
bleed. Blood was collected into EDTA-containing tubes and
plasma separated by centrifugation at 10,0009g for 10 min.
Plasma triacylglycerol (TAG), total cholesterol, and glucose
were measured by Biolis 24i Analyzer (Carolina Liquid
Chemistries, Winston-Salem, NC). Insulin was quantified
using the Alpco Mouse Ultrasensitive Insulin ELISA assay
(Alpco, Salem, NH); samples and controls were run in
duplicate, and optical densities were measured at 450 nm
using a microplate reader and analyzed with Gen5 Data
Analysis Software (Bio-Tek, Winooski, VT, USA). Plasma
TMAO quantification was performed at the UNC Chapel Hill
NORC Choline Metabolite Core using liquid chromatogra-
phy-stable isotope dilution-multiple reaction monitoring
mass spectrometry (LC-SID-MRM/MS). Briefly, plasma
was extracted with three volumes of acetonitrile spiked with
internal standards TMAO-d9 (DLM-4779-1, Cambridge
Isotope Laboratories), incubated on ice for 10 min, and
centrifuged at 15,0009g for 2 min. Supernatants were then
collected for instrumental analysis. Chromatographic sepa-
rations were performed on an Atlantis Silica HILIC 3 lm
4.6 9 50 mm column (Waters Corp, Milford, USA) using a
Waters ACQUITY UPLC system. The column was heated to
40 C, and the flow rate was maintained at 1 mL/min. The
gradient was 5 % A for 0.05 min, to 15 % A in 0.35 min, to
20 % A in 0.6 min, to 30 % A in 1 min, to 45 % A in
0.55 min, to 55 % A in 0.05 min, at 55 % A for 0.9 min, to
5 % A in 0.05 min, at 5 % A for 1.45 min, where A is 10 %
acetonitrile/90 % water with 10 mM ammonium formate
and 0.125 % formic acid and B is 90 % acetonitrile/10 %
water with 10 mM ammonium formate and 0.125 % formic
acid. TMAO and its corresponding isotope were monitored
on a Waters TQ detector using characteristic precursor-
product ion transitions: 76 ? 58 for TMAO, 85 ? 66 for
TMAO-d9. Concentrations of each metabolite in samples
were determined from its calibration curve using peak area
ratio of the metabolite to its isotope.
Microbiome Sample Processing
At baseline (on the AIN-93 diet), the mice were singly
housed for 24-h prior to fecal collection. For the final 4-h
of this period, mice were transferred to fresh bedding, food
was removed and feces were collected from each cage at
the end of this 24-h period for use in down-stream
microbiome studies. After 16 weeks of diet treatment, mice
were fasted for 4 h, blood samples collected and mice were
euthanized by isoflurane overdose and cecal samples col-
lected. Frozen (-80 C) fecal samples (1 pellet per animal)
or cecal contents (0.5 mg per animal) were homogenized in
lysis buffer (TissueLyser LT; Qiagen, Germantown, MD,
USA) (50 oscillations/second) for 120 s. DNA was
extracted from samples using the Maxwell 16 Tissue
DNA Purification Kit (Promega, Madison, WI) on a
Maxwell 16 Instrument (Promega, Madison, WI, USA).
One StepTM PCR Inhibitor Removal Kit (Zymo Research
Corp., Irvine, CA, USA) was used to remove contaminants
which may inhibit downstream PCR. Isolated DNA was
stored at -20 C until further use. Microbial community
composition was assessed by 16s rRNA gene sequencing.
Briefly, DNA encoding the V4 region of the 16s rRNA
gene was amplified using bar-coded fusion primers (F515/
R806) (Caporaso et al. 2012). The reverse PCR primer is
barcoded with a 12-base error correcting Golay code to
facilitate multiplexing, and both PCR primers contain
sequencer adapter regions [for full primer details see (Ca-
poraso et al. 2012)]. Briefly, genomic DNA samples
(10 ng/reaction) were amplified in triplicate (KAPA HiFi
PCR Kit, KAPA BioSystems, Woburn, MA, USA) with
10 lM final primer concentration. Reactions were held at
95 C for 3 min to denature DNA, followed by 35 ampli-
fication cycles of 94 C for 30 s, 50 C for 60 s, and 72 C
for 90 s, with a final 10 min extension at 72 C. Each set of
triplicate amplicons were cleaned using the Wizard
SVGel and PCR System (Promega, Madison, WI, USA),
and quantified using Qubit dsDNA HS Assay kit (Invitro-
gen, Oregon, USA). PCR products were run on an Expe-
rionTM 1 K DNA Chip (Bio-Rad, Hercules, CA, USA) to
assess DNA quality and confirm PCR product size. A
composite sample for sequencing was created by combin-
ing equimolar ratios of amplicons from the individual
samples. This amplicon mixture was sequenced
(2 9 250 bp paired end) on a MiSeq System (Illumina;
San Diego, CA, USA).
16s ribosomal RNA sequencing-based analysis
of intestinal microbial community structure
Raw sequence data were analyzed using Quantitative
Insights Into Microbial Ecology (QIIME) (Caporaso et al.
2010b) version 1.8.0. Forward and reverse paired-end reads
were stitched with the ea-utils fastq-join program (http://
code.google.com/p/ea-utils/) through QIIME. 150 bp was
set as the minimum overlap, and the effect of stitching
error stringency was assessed by varying the maximum
permitted error (0, 1, 3, 5 %). After paired-end stitching,
the raw fastq sequence file was demultiplexed in QIIME,
wherein each read meeting quality criteria (Phred score
A. O’Connor et al.: Host genetics influences microbial response to diet 585
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[25), was assigned to a sample ID. Sequences were then
clustered into operational taxonomic units (OTUs) de novo
using uclust (Edgar 2010), and a similarity threshold of
97 %. Representative sequences (most abundant sequence
in OTUs) were chosen, aligned to GreenGenes Core ref-
erence alignment (DeSantis et al. 2006) using PyNAST
(Caporaso et al. 2010a). Taxonomic classification was
assigned with Ribosomal Database Project (RDP) Classi-
fier 2.2 (Wang et al. 2007) through QIIME, and a phylo-
genetic tree built using FastTree 2.1.3 (Price et al. 2010).
The resulting biom-formatted OTU table was filtered to
remove singletons, and rarefied to an even sampling depth
of 51,000 reads/sample. Assessments of alpha-diversity
(number of observed species, Shannon Diversity Index,
GINI co-efficient) were conducted in QIIME. The biom-
formatted OTU table, mapping file, and phylogenetic tree
were imported into R Studio (v 3.0.1) via Phyloseq
(McMurdie and Holmes 2013), and beta-diversity assessed
by UniFrac (Lozupone and Knight 2005). Principle Co-
Ordinates Analysis (PCoA) was applied to reduce the
dimensionality of the resulting distance matrix. To deter-
mine the influence of strain and diet on global microbial
communities, UniFrac distance matrices were passed to the
R package Vegan (Jari Oksanen et al. 2013) for analysis of
similarity (ANOSIM), and Permutational Multivariate
Analysis of Variance (PERMANOVA). Hierarchical clus-
tering (Euclidean distance) was conducted using phyla
level relative abundance data in R Studio. To identify
discriminative microbial features between strains, relative
abundance data were analyzed using LDA effect size
(LEfSe)(Segata et al. 2011), an algorithm developed for
high-dimension data to identify features which characterize
biological conditions. LEfSe was implemented through the
Huttenhower Research Group Galaxy instance (http://hut
tenhower.sph.harvard.edu/galaxy/). Heritability was calcu-
lated as described by Hegmann and Possidente using the
following formula h2 ¼ 0:5Va=ð0:5Va þ VeÞ where Va is
the additive genetic variance and Ve is the average envi-
ronmental variance (Hegmann and Possidente 1981).
Evaluating relationships between 16s-based phylogeny,
predicted function and metabolic phenotypes
Correlations between relative abundance of individual taxa
and cardiometabolic phenotypes were assessed by spearman
rho. All p values were adjusted using false discovery rate
(FDR) of 10 % using the q value package (Storey 2002) in the
R programing environment. To predict metagenomic func-
tional content from our 16s rRNA survey, the software
package Phylogenetic Investigation of Communities by
Reconstruction of Unobserved States (Langille et al. 2013)
(http://picrust.github.io/picrust/) was used. This computa-
tional approach exploits the relationship between phylogeny
and function by combining 16s data with a database of ref-
erence genomes (GreenGenes) to predict presence of gene
families. Briefly, OTUs were picked with a closed reference
protocol against GreenGenes v 13.5 through QIIME. The
resulting biom-formatted OTU table was uploaded to Galaxy
(http://huttenhower.sph.harvard.edu/galaxy/) for 16s copy
number normalization and metagenomic prediction. Func-
tional predictions were exported as KEGG orthologs.
Results
Sequencing depth and paired-end stitching optimization
To determine the impact of stitching error stringency, and
sequencing depth on global measures of community structure,
and to fine-tune parameters for down-stream analysis, paired-
end (2 9 250) Illumina MiSeq reads were stitched with
varying levels of maximum permitted error (0, 1, 3, and 5 %)
from mice fed the purified synthentic diet (AIN-93A). OTU
tables resulting from the four levels of stitching error strin-
gency were rarefied at multiple sequencing depths
(1,000–96,000 reads/sample in steps of 5,000 reads/sample; 3
OTU tables generated per rarefaction point). This analysis
highlighted a plateau in the number of taxa identified from a
sequencing depth of approximately 50,000 reads/sample
onward (Supplementary Fig. 1). Hence for all down-stream
analyses, a rarefaction depth of 51,000 reads/sample was
deemed acceptable. The numbers of taxa identified at each
taxonomic ranking were comparable between stitching strin-
gency levels, although a drop-off for maximum permitted
error of 0 and 1 % was seen, likely due to the reduction in
sample size which occurred with increased stringency at
higher sequencing depths. Decreasing permitted stitching
error increased Shannon Diversity Index, a measure of alpha-
diversity, which is due at least in part to a decrease in evenness
(as assessed using the GINI coefficient) as permitted error in
stitching decreased (Supplementary Fig. 1). Based on these
comparisons, down-stream analyses were conducted using a
maximum permitted error of 3 %, and a sequencing depth of
51,000 reads/sample. These parameters provided the greatest
compromise between maximizing diversity in the dataset and
minimizing sample size drop-off, while permitting the lowest
possible error rate during paired-end read stitching.
Cardiometabolic phenotypes are differentially
influenced by genetic background and atherogenic
feeding
Mice are effective models of cardiovascular disease
(Reardon and Getz 2001), and thus we quantitated these
mice for the following traits associated with cardiovascular
disease (Go et al. 2013) which we refer to as
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cardiometabolic traits: body weight, adiposity, and plasma
levels of lipids, insulin, glucose and trimethylamine
N-oxide (TMAO). Differences in cardiometabolic risk
factors between strains of mice fed purified synthetic diet
(AIN-93 M) are shown in Fig. 1. Significant differences
were seen across strains for body weight (ANOVA
F = 42.31, p \ 0.0001), % lean mass (ANOVA
F = 97.09, p \ 0.0001), % fat mass (ANOVA F = 34.11,
p \ 0.0001), total cholesterol (ANOVA F = 9.7, p \
0.0001), plasma TAG (ANOVA F = 4.6, p \ 0.0001),
TMAO (ANOVA F = 9.12, p \ 0.0001), fasting plasma
glucose (ANOVA F = 7.09, p \ 0.0001), fasting insulin
(ANOVA F = 13.96, p \ 0.0001), and HOMA-IR
(ANOVA F = 7.5, p \ 0.0001) (Fig. 1). These plasma
lipid levels and adiposity for the inbred strains in our study
are comparable to previously reported studies at the Mouse
Phenome Database (www.phenome.jax.org) (Grubb et al.
2014). Body weight was comparable to Paigen 1; total
cholesterol and TAG were comparable to Paigen 2, and
adiposity measures were comparable to Naggert 1.
Strain- and diet-dependent changes in cardiometabolic
related traits (cholesterol, TAG, adiposity, insulin, and
TMAO) were evident after 16 weeks of the diet treatment
(Fig. 2), highlighting the influence of genetic background
on diet-driven susceptibility to disease. A significant strain
effect (F = 11.81, p \ 0.0001) was seen for percentage fat
mass change and glucose (F = 8.42, p \ 0.0001) (Sup-
plementary Fig. 2). Significant strain and diet effects
(HFCA compared to LFCC) were seen for change in total
plasma cholesterol concentrations (F = 2.56, p = 0.67;
F = 7.34, p = 0.009, strain and diet, respectively). A
significant strain (F = 8.62, p \ 0.0001) and strain–diet
interaction (F = 2.87, p = 0.017) was seen for plasma




Fig. 1 Cardiometabolic phenotypes between inbred mouse strains
fed a synthetic diet. Inbred mouse strains were purchased from
Jackson Laboratories at *6 weeks, and placed on purified synthetic
diet (AIN-93). After 2 weeks, animals were weight, body composition
assessed by MRI and fasting plasma samples collected. Differences in
bodyweight (a), and body composition by MRI are depicted as
percentage fat mass (b), percentage of lean mass (c). Fasting plasma
levels of cholesterol (d), triglycerides (e) and TMAO (f) were
quantitated. Measures of insulin sensitivity were assessed and
included plasma glucose (g), insulin (h) and calculated HOMA-IR
(i). p-value for ANOVA \0.05 for all phenotypes. Significant
between-strain differences identified with Tukey’s HSD post hoc
test. Strains not sharing letter are significantly different (p \ 0.05)
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2-way ANOVA of post-diet phenotypes revealed a signif-
icant independent effect of strain only on final body weight
(F = 109.598, p \ 0.0001), % fat mass (F = 94.54,
p \ 0.0001), % lean mass (F = 91.17, p \ 0.0001), glu-
cose (F = 3.60, p \ 0.0038), insulin (F = 7.65,
p \ 0.0001), and HOMA (F = 7.53, p = 0.0001). A sig-
nificant main effect of diet only was seen for total plasma
fasting cholesterol (F = 8.85, p = 0.0047). Regulation of
plasma TMAO levels is complex and is highly influenced
by both the effect of genetic background of the mice
(F = 12.97, p \ 0.0001) and in response to dietary treat-
ment (F = 6.32, p = 0.0159) (Fig. 2f). We observed
a significant strain–diet interactions for plasma TMAO
(F = 2.96, p 0.0129) (Supplemental Fig. 2E).
Microbial community structure is driven by host
genetic background
The baseline V4 amplicon library contained 5,490,587
reads after quality filtering (average 103,596/sample;
range = 128–285,838 reads/sample). 3 samples were
removed from the dataset as assigned reads fell below the




Fig. 2 Atherogenic diets induce strain-dependent differences in
cardiometabolic phenotypes. Following 16 weeks on either a high-
fat cholic acid (HFCA; open bars) diet or low-fat cholesterol-
containing diet without cholic acid (LFCC; shaded bars). Differences
in Bodyweight (a), and body composition by MRI are depicted as
percentage fat mass (b), percentage of lean mass (c). Fasting plasma
levels of cholesterol (d), triglycerides (e) and TMAO (f) were
quantitated. Measures of insulin sensitivity were assessed and
included plasma glucose (g), insulin (h) and calculated HOMA-IR
(i). Significant within-strain differences between diet groups assessed
by independent t-tests. *p \ 0.05, **p \ 0.01, ***p \ 0.001,
****p \ 0.0001
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sequence library comprised 42,130 assigned OTUs which
collapsed to 82 bacterial taxa.
To explore the influence of genetic background on alpha-
diversity under baseline nutrient intake, Shannon diversity
index as well as the number of observed OTUs was calcu-
lated. This analysis revealed a significantly reduced diversity
in PWK/PhJ samples compared with all other mouse strains
(Supplementary Fig. 3). GINI coefficient, a measure of
evenness in abundance distribution across OTUs within a
sample, was modestly but significantly increased in PWK/
PhJ samples, suggesting a more even distribution of abun-
dances among bacterial taxa in the PWK/PhJ intestinal
environment. Lower levels of alpha-diversity have been
related to adverse metabolic phenotypes and reduced
responsiveness to weight loss interventions (Cotillard et al.
2013; Le Chatelier et al. 2013).
To determine the impact of strain on intestinal phylotypic
diversity, UniFrac—a measure of phylogenetic similarity—
was performed. Principle Coordinates Analysis (PCoA) of
unweighted UniFrac distances revealed a strong effect of
host genetics on gut microbial community membership. A
distinct cluster consisting of C57BL/6J samples and a second
cluster consisting of the wild-derived strains PWK/PhJ and
WSB/EiJ were observed, with the remaining mouse strains
clustering more closely in a third group (Fig. 3a and b).
Analysis of Similarity (ANOSIM) on this UniFrac distance
matrix revealed a significant difference between mouse





Fig. 3 Global regulation of intestinal microbiome communities by
genetic background in mice fed a purified synthetic diet. (a) Principle
coordinates analysis (PCoA) of unweighted uniFrac. (b) Principle
component 1 of unweighted UniFrac. (c) Phyla level relative
abundance data. (d) Linear discriminant analysis with effect size
(LEfSe) identified differentially abundant taxa between mouse strains.
Taxa enriched in A/J (yellow), C57Bl6/J (gray), 129S1/SvlmJ (pink),
NOD/ShiLtJ (dark blue), NZO/HiLtJ (light blue), CAST/EiJ (green),
PWK/PhJ (red), and WSB/EiJ (purple) meeting LDA significant
threshold [2 are shown
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significant effect of mouse strain on microbial community
structure (PERMANOVA R2 = 0.33, p \ 0.0001).
At a phylum level, the abundance of Firmicutes was
dominant across inbred strains (range 61.8–95.4 %)
(Fig. 3c), as has been described previously (Spor et al.
2011). Bacteroidetes was prominent in all samples (range
4.2–24.1 %). Gram-positive Actinobacteria were enriched
in C57BL/6J samples only (6.8 % vs \0.2 % in all other
samples), and the relatively recently described phylum,
Verrucomicrobia, was enriched in PWK/PhJ and NOD/
ShiLtJ only (12.9 and 14.1 % relative abundance respec-
tively, vs \0.2 % in all other mouse strains). Other phyla
detected at low abundance (\1 %) were Thermi, Teneri-
cutes, and Proteobacteria. Together these phyla comprised
0.003–0.56 % of total community composition (Fig. 3c).
Linear Discriminant Analysis (LDA) was used to iden-
tify differentially abundant taxa between groups of inbred
strains (Fig. 3d). Feces of C57Bl/6J animals was enriched
for Actinobacteria (class) and Tenericutes (phylum)
(Fig. 3d), and NOD/ShiLtJ samples were enriched for
Verrucomicrobia, specifically A. muciniphila, the only
member of the Verrucomicrobia phylum identified in this
dataset, similar to that reported elsewhere (Derrien et al.
Table 1 Heritability estimates of genus level taxa in CC/DO founder
strains on AIN-93 diet (baseline group)
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2011). The majority of discriminatory factors were mem-
bers of the Firmicutes phylum, consistent with this being
the dominant phylum across samples. Interestingly, wild-
derived inbred strains (CAST/EiJ, PWK/PhJ, WSB/EiJ) are
enriched for several genus-level members of Clostridiales,
a dominant class of commensal bacteria (Dehalobacterium,
Rumminococcus, Oscillospira genera), in addition to the
genera Lactococcus and Coprobacillus (Firmicutes phy-
lum) (Fig. 3d).
As genetics has previously been reported to exert
greatest control at the tips of the phylogenetic tree (Benson
et al. 2010), heritability estimates using genus level taxa
relative abundances were calculated (Table 1). Our ana-
lysis further confirms both the influence of genetic back-
ground on microbial community structure and the specific
nature of the regulation of individual taxa, as we identify a
wide range of heritability for genus-level taxa (26–86 %).
Whereas phylotyping has enabled an understanding of
the taxonomic distribution and diversity of enteric micro-
bial communities, understanding the functional metabolic
underpinnings of the intestinal microbiota can provide
significant depth to our understanding of microbiota in
health and disease. Using PICRUSt, a computational
approach to infer metagenome content from 16 s data, the
metagenomic metabolism was predicted and seen to vary
across strains, with significant between-strain differences
seen in aspects of metabolism (amino acid, lipid, glycan,
terpenoids and polyketoids, and secondary metabolites)
(Supplementary Fig. 4), as well as pathways involved in
basic functioning (cellular processes, environment, and
genetic information processing). Significant differences in
pathways enriched for genes involved in diseases (cancers,
cardiovascular disease, immune system, infectious disease,
metabolic disorders), and organ systems (digestive, endo-
crine) were observed (Supplementary Fig. 4), many of
which were significantly related to cardiometabolic phe-
notypes (Supplementary Fig. 5).
Atherogenic diet-driven shifts in microbial
communities are strain-dependent
V4 16s rRNA libraries amplified from post 16 week diet
intervention cecum DNA samples contained 6,388,210
reads after quality filtering (average 110,141/mouse;
range = 298–212,914 reads/sample). 2 samples were
removed from the dataset as assigned reads fell below the
rarefaction point of 51,000 reads/sample. This sequence
library comprised 29,326 assigned OTUs which also col-
lapsed to 82 distinct bacterial taxa.
To investigate potential atherogenic diet-associated
shifts in microbial community structure, several measures
of alpha-diversity were conducted. Including all three diet
groups in the analysis (AIN-93 M, HFCA, LFCC), 2-way
ANOVA analysis revealed significant diet, strain, and diet–
strain interactions on GINI co-efficient (F = 8.48,
p \ 0.0001; F = 72.773, p \ 0.001; F = 3.698,
p \ 0.0001; diet, strain, and diet–strain, respectively),
Shannon Diversity Index (F = 6.51, p \ 0.0001;
F = 122.4, p \ 0.0001; F = 5.37; p \ 0.0001 diet, strain,
and diet–strain, respectively), and number oF observed
OTUs (F = 13.46, p \ 0.0001; F = 116.77, p \ 0.0001;
F = 5.50, p \ 0.0001 diet, strain, and diet–strain, respec-
tively). Compared with fecal AIN-93M samples, cecal
samples from both HFCA and LFCC diet groups exhibited
reduced alpha-diversity in a strain-dependent manner
(Supplementary Fig. 6), with A/J, C57BL/6J, 129S1/
SvlmJ, NOD/ShiLtJ, NZO/HILtJ, and WSB/EiJ experi-
encing a decrease in all measures of alpha-diversity from
AIN-93M to HFCA (Supplementary Fig. 6). This reduction
in alpha-diversity was less evident between the baseline
and LFCC diet groups, with only A/J, and 129S1/SvlmJ
experiencing a significant reduction. Consistent with the
antimicrobial effects of cholic acid (Islam et al. 2011),
alpha-diversity was reduced in HFCA samples compared
with LFCC, although this reduction was significant for A/J,
C57BL/6J, NOD/ShiLtJ, and NZO/HILtJ animals only
(Supplementary Fig. 6).
When the HFCA and LFCC datasets were combined, a
significant effect of strain remained evident (PERMANO-
VA R2 = 0.31, p \ 0.0001), and a significant effect of diet
(PERMANOVA R2 = 0.065, p \ 0.0001) as well as a
significant strain–diet interaction effect (PERMANOVA
R2 = 0.20, p \ 0.0001) on beta-diversity were observed
(Fig. 4C). However, analyzing the HFCA and LF diet
groups in isolation revealed a more pronounced effect of
strain on microbial community structure (HFCA group
PERMANOVA for strain R2 = 0.55, p \ 0.0001; LF
group PERMANOVA for strain R2 = 0.54, p \ 0.0001)
(Fig. 4a and b), indicating that environmental challenges
such as increased bile acids and dietary fat can lead to a
sharper discrimination between strains, and highlighting
the influence of genetic background in mediating the
microbial response to diet. Furthermore, certain strains
(A/J, C57BL/6J, WSB/EiJ) separated clearly by diet, while
other potentially less dietary responsive strains (NOD/
ShiLtJ, CAST/EiJ) cluster less distinctly (Fig. 4D).
Due to differences in sampling sites, direct comparisons
between the baseline (feces) and post-diet (cecum) samples
were not made. However, a high-level view of phyla dif-
ferences between fecal microbial communities at baseline
(AIN-93M), and cecal samples from both HFCA and LFCC
diet groups show an increase in relative abundances of
Verrucomicrobia and Bateroidetes with corresponding
decreases in Firmicutes (data not shown) after 16-week
dietary intervention. The increased abundance of the
mucin-degrading Verrucomicrobia post diet may be driven
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by sampling site differences (feces at baseline and cecum
post diet), as greater mucin production and also greater A.
muciniphila (Verrucomicrobia phylum) has been reported
in the cecum compared with other intestinal sites (Derrien
et al. 2011).
To determine differentially abundant taxa between
HFCA and LFCC diet groups, post diet relative abundance
data were analyzed using LDA. This analysis identified 20
differentially abundant taxa (Fig. 4E) regulated by the two
HFCA and LFCC cholesterol containing diets. In addition
to a main effect of diet on these taxa, significant diet–strain
interactions were observed for the genera A. mucinipila
(phylum Verrucomicrobia), Clostridium, Dehalobacterium,
Rumminococcus gnavus, Turicibacter (phylum Firmi-
cutes), Desulfovibrio (phylum Proteobacteria), the order
Coriobacteriales (phylum Firmicutes), and the families
Clostridiaceae, Rumminococcaceae (phylum Firmicutes),
and S2-47 (phylum Bacteroidetes). Many of these genetic
and dietary regulated taxa form part of the core group of
cardio-metabolic related taxa, described in detail below,
related to body weight, body composition (proportions of
lean and fat mass), plasma lipids, and the atherogenic
metabolite TMAO (Fig. 5).
Baseline and diet-induced relationships
between microbial taxa and key cardiometabolic
phenotypes
After correction for multiple testing, we identified signifi-
cant relationships between phenotypes and a core group of
cardiometabolic-related microbial taxa (Fig. 5).
On purified synthetic diet (AIN-93 M, baseline nutri-
tional conditions), fasting plasma TMAO concentrations, a
metabolite of microbial and dietary-derived TMA, was
negatively correlated with butyrate producers such as
unclassified microbiota in the Lachnospiraceae family
(phylum Firmicutes, order Clostridiales), as well as the
Roseburia genus within the Lacnospiraceae family. TMAO
A B C
D E
Fig. 4 Global diet and strain-driven regulation of microbial beta-
diversity. PCoA of Unweighted UniFrac of: (a) HFCA samples only;
(b) LFCC samples only; (c) HFCA and LFCC samples combined;
and, (d) HFCA, LFCC and AIN93M samples faceted by strain;
(e) Linear discriminant analysis with Effect Size (LEfSe) identified
differentially abundant taxa between HFCA and LFCC diet groups.
Taxa enriched in HFCA diet (gray) and those enriched in LFCC diet
(red) meeting LDA significant threshold[2 are shown. Taxa enriched
in LF versus HFCA diet have a negative LDA score
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was positively correlated with the genus Bifidobacterium
(phylum Actinobacteria), as well as unclassified members
of the RF39 order (Tenericutes phylum, class Mollicutes)
(Fig. 5). Positive relationships between TMAO and Rum-
minococcaceae and Erysipelotricaceae (families within
Firmicutes phylum), and the genus Lactobacillus (Firmi-
cutes phylum), were also identified (Fig. 5). Several of
these relationships (Bifidobacterium, Lactobacillus, Erysi-
pelotrichaceae) were maintained following atherogenic
dietary intervention (Fig. 5), suggesting that these are sta-
ble genotype-driven taxa * phenotype relationships which
are less influenced by the environmental effects of ath-
erogenic dietary nutrients (cholesterol, fat, cholic acid).
Following atherogenic diet consumption, several new
relationships between TMAO and microbial taxa were
identified. TMAO was positively correlated with Turicib-
acter and Streptococcus, two genera within class Bacilli
(phylum Firmicutes), unclassified members of Peptostro-
poccaceae family (phylum Firmicutes), as well as the genus
Desulfovibrio (phylum Proteobacteria). A diet-induced
negative relationship was identified between TMAO and
Coprobacillaeae (phylum Firmicutes).
At baseline, significant relationships were identified
between body weight and body composition (fat and lean
%) (Fig. 5). Several genera within the Clostridiales order
(Anaerotruncus, Blautia, Roseburia) exhibited opposing
relationships between weight/fat and lean mass (Fig. 5).
However, although the direction of many of these
Fig. 5 Significant relationships between microbial taxa and cardio-
metabolic phenotypes exist in mice fed purified synthetic diets
(baseline) and atherogenic diets for 16 weeks (post diet). Correlations
between taxa and phenotype assessed by Spearman rho. Asterisks
denotes significant relationship (p values adjusted FDR 10 %)
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relationships was retained post diet, the magnitude
decreased, and none of these baseline relationships reached
significance post diet. Additionally, no novel atherogenic
diet-induced relationships were identified for these body
composition phenotypes.
At baseline, fasting plasma TAG concentrations were
negatively correlated with relative abundance of unclassified
members of the order RF39 (phylum Tenericutes, class
Mollicutes), and families Planococcoceae, Enterococca-
ceae), and Ruminocoocoeae (all Firmicutes phylum). TAG
was positively correlated with relative abundance of R.
gnavus (family Lachnospiraceae, phylum Firmicutes)
(Fig. 5). This positive relationship with R. gnavus persisted
following atherogenic dietary intervention (Fig. 5). Dietary
intervention increased the strength of the positive relation-
ship between TAG and the genera Anaerotruncus and Co-
probacillus (phylum Firmicutes), and these relationships
reached significance at the post-diet time-point only (Fig. 5).
Other relationships between plasma TAG and microbial taxa
abundance were lost after atherogenic feeding (Fig. 5).
Although no significant relationships existed between
plasma total cholesterol and taxa at baseline, after atherogenic
feeding, diet-induced positive relationships between fasting
plasma cholesterol and family Rikenellaceae (phylum Bac-
teroidetes), and Coprobacillaceae (phylum Firmicutes) were
revealed (Fig. 5). Additionally, dietary-responsive negative
relationships between genera Bifidobacterium (phylum Ac-
tinobacteria), Allobaculum, Turicibacter, Lactobacillus,
Streptococcus (phylum Firmicutes), and Desulfovibrio (phy-
lum Proteobacteria) were identified (Fig. 5).
No significant correlations were identified between
glucose, insulin or HOMA-IR and microbial abundance at
baseline, however, at the post diet time-point, fasting
plasma glucose was negatively correlated with genera
Lactobacillus, Enterococcus (class Bacilli, phylum Firmi-
cutes), and families Peptococcaceae and Erysipelotricha-
ceae (phylum Firmicutes). Glucose was positively
correlated with genera Ruminococcus and Oscillospira
(family Rumminococcaceae), and Dehalobacterium (fam-
ily Dehalobacteriaceae), Butyribrio and R. gnavus (family
Lachnospiraceae) (all Clostridiales order, phylum Firmi-
cutes). Atherogenic feeding strengthened the negative
relationship between Rumminococcaeae and insulin,
reaching significance post diet only, and revealed a novel
positive dietary-responsive relationship between Bacteroi-
des caccae (phylum Bacteroidetes) and insulin (Fig. 5).
Discussion
Recent reports have highlighted interactions between the
microbiome and metabolism of dietary components such as
phosphatidylcholine and carnitine on modulating cardio-
vascular disease risk (Koeth et al. 2013a; Tang et al. 2013;
Wang et al. 2011), and have identified numerous associa-
tions between the microbiome and metabolic diseases. In
the current report, we use a segregating panel of inbred
mouse strains, representing *90 % of the genetic variation
in mice (Roberts et al. 2007), to examine the effects of
genetics on intestinal microbiota and cardiometabolic risk
factor response to diet. There are five main findings of our
current studies: (1) differences in enteric microbial com-
munities between inbred mouse strains are evident; (2)
some of these strain-driven differences are retained and
become more pronounced with dietary intervention; (3)
microbial and phenotypic response to diet varies by mouse
strain; (4) differences between the mouse strains suggest
underlying differences in intestinal barrier function,
inflammatory environment, short chain fatty acid (SCFA)
production, and bile acid metabolism; and (5) the observed
differences in a core group of microbial taxa are signifi-
cantly related to cardiometabolic phenotypes. These results
highlight not only the influence of genetic background on
microbiome community structure but also on the microbial
and phenotypic response to diet, and illustrate the effec-
tiveness of the CC/DO founder strains in nutrigenomic
studies.
The significant effect of mouse strain echoes that of recent
work demonstrating that microbial composition in the
intestine is a complex, polygenic trait. Numerous genetic
studies in mice, including those using genetic reference
panels (Benson et al. 2010; Campbell et al. 2012; Hildebrand
et al. 2013; McKnite et al. 2012), have demonstrated an
effect of genetic background on microbial diversity. Inter-
estingly, Benson and co-workers demonstrated that multiple
taxa can co-localize to a single QTL, suggesting that a single-
genetic locus may regulate the abundance of several taxa
(Benson et al. 2010). A previous survey using founder strains
of the CC (Campbell et al. 2012) also reports a significant
effect of mouse strain on microbial diversity, although few
discriminating OTUs were identified, and differences were
not linked to phenotype. Our current study has sharper dis-
crimination between inbred mouse strains potentially due to
*10 fold increase in sequencing depth, differing sites of
microbial assessment for the baseline comparison (cecum vs
feces), and the use of a synthetic defined diet which avoid the
variation inherent in non-purified diets (Reeves et al. 1993).
In the current study, C57Bl6/J animals had differentially
abundant members of the Actinobacteria phylum. These
results mirror those of previous studies which have demon-
strated an effect of the C57Bl6/J allele in a QTL regulating
Actinobacteria abundance (Benson et al. 2010).
To ensure the host-microbial relationship remains har-
monious, a sophisticated host antigen recognition and
defense system has developed to prevent microbial
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invasion. Considering this tension between microbial
populations and the host immune system, it is not sur-
prising that immune function is a recurring theme in the
host-genetic regulation of microbial abundance. A large
proportion of QTL regions reported to regulate microbial
abundance contain genes related to immunity and mainte-
nance of barrier function (Benson et al. 2010; McKnite
et al. 2012; Srinivas et al. 2013). The influence of immune-
related genes is further evidenced by the dramatic effects
on microbial community structure caused by mutations in
single genes related to host immunity (Thompson et al.
2010; Wen et al. 2008). Hildebrand and co-workers show
that microbiota cluster by fecal calprotectin concentrations,
with high fecal calprotectin indicative of an inflammatory
colonic environment (Hildebrand et al. 2013). Several taxa
identified as being differentially abundant between strains
in our study, such as members of the Clostridiales order,
are known to be decreased in intestinal inflammatory
environments (Schwab et al. 2014), suggesting that dif-
ferences in immune response may underlie strain-depen-
dent differences observed, as has been indicated by
previous studies (Benson et al. 2010; McKnite et al. 2012;
Srinivas et al. 2013).
In order to test genetic background, environmental for-
ces must be steady and carefully controlled. Factors such as
the maternal environment, litter effects, cage mates, the
location that the mice are housed, and the commercial
vendor, can influence microbial populations (Benson et al.
2010; Campbell et al. 2012; Friswell et al. 2010; Hilde-
brand et al. 2013). Currently, the relative strength of
environmental versus genetic signals on microbial regula-
tion is unclear. Uterine implantation studies have shown
that mice of different genetic backgrounds have similar
microbial composition when reared by the same foster
mother, indicating that in certain circumstances, environ-
mental drivers can overpower genetic influences at least for
non-adherent bacterial populations (Friswell et al. 2010).
As animals were purchased from a commercial vendor, the
current study does not permit a full investigation of envi-
ronmental forces influencing enteric bacterial populations.
Although the existence of within strain cage effects has
been clearly illustrated in the literature (McCafferty et al.
2013), these were not evident in the current study. Co-
housing within strains during transportation, use of syn-
thetic diet (as oppose to standard chow or non-purified diet
which can be variable in composition), or singly housing
for 3-days prior to fecal collection (during which time the
impact of cage may have begun to rescind), are possible
reasons for the close clustering seen within strains.
Considering that the microbiome depends on dietary and
host-derived nutrients for survival, it is unsurprising that
dietary intake has such a profound impact on the microb-
iome (Cotillard et al. 2013; Spor et al. 2011). Altered
dietary nutrient composition can lead to a bloom or wane in
certain microbiota with varying capacity to flourish under
changing environmental conditions. Shifts in underlying
microbial function and metabolism can have secondary
effects on host metabolism. Rather than overwhelm the
effect of mouse strain, dietary intervention resulted in a
stronger main effect of mouse strain on microbial com-
munity structure. Interestingly, the separation within
mouse strains by diet was variable across the inbred lines,
and certain cardiometabolic-related taxa exhibited diet–
genotype interaction effects, suggesting variable microbial
responsiveness to external dietary influences as is seen
phenotypically with these strains. Although this is a rela-
tively new area of focus, other groups using mouse genetic
reference populations (Parks et al. 2013b), or single gene
knockout models (Kashyap et al. 2013) have demonstrated
an interaction between microbiota and diet that is influ-
enced by host genotype. Recent work with human partic-
ipants reported that despite retained variation in taxonomy
following dietary intervention, microbial gene expression,
as assessed by RNAseq, clustered by diet group and
exhibited less between-subject variation than at baseline
(David et al. 2014). Considering this, it is unclear whether
the taxonomic separation seen between strains post diet
reflects variable metabolic functionality, which would in
turn impact host phenotype. However, our core group of
cardiometabolic-related taxa are good candidates for future
focus.
The microbiome is a metabolically active, complex
organ, producing many metabolites which can directly
influence host phenotype. Genetic and dietary regulated
taxa identified in this study were enriched for known
SCFA, bile acid and inflammation and barrier function-
related taxa. Recent efforts have focused on the link
between the microbiome and the atherogenic metabolite
TMAO. TMAO is formed from trimethylamine (TMA)
via hepatic flavin mono-oxygenase 3 (FMO3) (Bennett
et al. 2013a). The microbiome plays an obligate role in
the formation of TMA (from trimethylamine-containing
nutrients choline and carnitine), and antibiotic knockdown
studies show clearly that TMAO is not formed in the
absence of the microbiome (Tang et al. 2013). Bacterial
species harboring putative choline utilization gene clusters
(cut-c) have been suggested to play a central role in
enteric TMA formation (Craciun and Balskus 2012) (and
therefore down-stream TMAO production), however the
specific microbiota have not been fully ascertained. In
addition to the microbial differences in TMA production,
differences in Fmo3 gene expression can contribute to
TMAO levels as we have previously reported that Fmo3
both has a cis-eQTL and is correlated with plasma TMAO
levels (Bennett et al. 2013b). Thus, variation in the mi-
crobiome and Fmo3 gene expression contribute to plasma
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TMAO levels. Our current studies focus on the genetic
regulation of the gut microbiome and relationships with
TMAO and other cardiovascular risk factors. A previous
report that plasma TMAO and members of the Teneri-
cutes phylum (Koeth et al. 2013b) are correlated was
confirmed in our current study. Additionally, we see a
significant negative correlation between plasma TMAO
concentrations and members of the Lachnospiraceae
family including the Roseburia genus, a known butyrate
producer. Other members of this family were also nega-
tively correlated although failed to reach significance after
correction for multiple testing. We identified a number of
dietary responsive relationships related to plasma TMAO
levels, including positive relationships between the genus
Desulfovibrio, a member of the sulfate/sulfite reducing
Desulfovibrionaceae family. A species within the Des-
ulfovibrio genus has been demonstrated to degrade cho-
line to TMA (Craciun and Balskus 2012), hence an
increased formation of this TMAO precursor may explain
this positive relationship.
Several elegant studies have clearly established a role
for the microbiome in regulation of body weight and adi-
posity (Backhed et al. 2004; Ridaura et al. 2013). A shared
genetic regulation has also been reported, with genetic loci
regulating body composition complex traits coinciding
with loci regulating microbial abundances (McKnite et al.
2012; Parks et al. 2013a). The negative relationship
between body weight and fat mass, and the positive rela-
tionship between lean mass and Roseburia, Blautia and
other unclassified genera of the Lachnospiraceae family
suggests a relationship between butyrate production in the
intestine and body weight control. In addition to providing
a nutrient source for the enteric epithelium (De Vadder
et al. 2014), butyrate plays a role in modulating host energy
expenditure (Gao et al. 2009). Additionally, butyrate can
influence gut peptide secretion with potential secondary
effects on satiety (Hosseini et al. 2011) via SCFA receptors
such as GPR43 (Kimura et al. 2013).
The influences of bacterial taxa with opposing roles in
barrier function on plasma lipids and other metabolic
markers highlights the importance of barrier function for
metabolic health. Bifidobacterium longum, known to pro-
mote tight junction integrity, was associated with decreased
plasma TAG suggesting a protective role. On the other
hand, R. gnavus, a mucin-degrading species associated
with reduced barrier integrity and bile acid metabolism,
was positively related to TAG and plasma glucose. Barrier
function is crucial to guard against bacterial translocation
and metabolic endotoxemia which has been directly linked
to metabolic disease increased fasting glycemia, decreased
glucose tolerance, increased body and liver weight,
increase liver triglyceride content and increased energy
intakes (Cani et al. 2007).
The genetic variation of the CC/DO founders coupled
with dietary perturbation revealed a core group of geneti-
cally and dietary regulated microbial taxa, many of which
are connected to cardiometabolic phenotype. Many of the
taxa identified have strong plausible roles in mediating host
phenotype, and as they appear regulated by both genetics
and diet, may represent useful targets in understanding
diet-induced variability in metabolic disease risk. The
specific relationship of these taxa to human disease remains
to be confirmed as the microbial composition of humans
and mice are similar at the phyla level but may not contain
the same specific species of microbiota (Ley et al. 2005).
In conclusion, our results provide a strong indication
that host genetics drives microbial diversity under baseline
nutrient conditions, and in response to atherogenic nutrient
intake. We also highlight that genetic–diet influences on
the microbiome are related to cardiometabolic phenotypes,
suggesting that differences at the level of the intestinal
microbiome may underlie some of the differences in
mouse-strain dependent susceptibility to cardiovascular
disease and metabolic ill health in response to atherogenic
diets. Understanding how diet responsive microbiota are
influenced by genetics and importantly contribute to host
phenotype will be pivotal in fully realizing the potential for
personalized nutrition and our comprehension of inter-
individual variation in disease risk. Segregating panels of
mice such as the CC/DO founders provide wide scope of
variation which can be probed in depth in future studies.
Underlying differences in gene expression and fecal
metabolites will shed more light on host-derived changes in
functional and metabolic capacity of the microbiome, and
provide greater insight into mechanisms by which these
changes influence host phenotype.
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